Table 3.
Local and national cumulative numbers as reported until May 15 by the UK Renal Registry
| Locality | Total RRT (n) | Hemodialysis Population | Peritoneal Dialysis Population | ||||||||
| Total ICHD (n) | SARS-CoV-2 (n) | Death (n) | Case-Fatality Ratio (%) | P Value | Total PD (n) | SARS-CoV-2 (n) | Death (n) | Case-Fatality Ratio (%) | P Value | ||
| All three hospitals | 1737 | 224 | 51 | 23% (17%, 28%) | — | 228 | 10 | 6 | 60% (30%, 90%) | — | |
| London | 14394 | 1021 | 219 | 21% (19%, 24%) | 0.67 | 44 | 12 | 27% (14%, 40%) | 0.26 | ||
| England | 56201 | 2134 | 502 | 24% (22%, 25%) | 0.80 | 78 | 25 | 32% (22%, 42%) | 0.30 | ||
| United Kingdom | 66612 | 2326 | 553 | 24% (22%, 26%) | 0.74 | 84 | 26 | 31% (21%, 41%) | 0.29 | ||
The P values are consistent with no difference between the case-fatality ratio in our sample and those in London, England, and the United Kingdom. Our data suggest some evidence that the case-fatality ratio is higher in patients on PD (six of ten) than in HD (51/224) and patients (P=0.015 according to Fisher exact test). ICHD, in-center hemodialysis; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; PD, peritoneal dialysis; HD, hemodialysis. The case fatality ratio are accompanied by their 95% CI, i.e., calculated using standard errors of the sample proportion.